ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Immutep Receives Second IND approval for Efti from FDA americanpharmaceuticalreview
March 10, 2020Immutep has announced the approval of its Investigational New Drug (IND) application by the United States Food and Drug Administration (FDA) for eftilagimod alpha (efti or IMP321).
Pharma Sources Insight January 2025
